Filing Details
- Accession Number:
- 0001181431-10-008611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-11 12:00:00
- Reporting Period:
- 2010-02-09
- Filing Date:
- 2010-02-11
- Accepted Time:
- 2010-02-11 20:34:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 19520 | Chattem Inc | CHTT | Pharmaceutical Preparations (2834) | 620156300 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 217028 | Aventis Inc | 3711 Kennett Pike, Suite 200 Greenville DE 19807 | No | No | Yes | No | |
| 1121404 | Sanofi-Aventis | 174, Avenue De France Paris I0 75013 | No | No | Yes | No | |
| 1421144 | S.n.c. Nord Du Amerique Sanofi-Aventis | 174, Avenue De France Paris I0 75013 | No | No | Yes | No | |
| 1480102 | River Acquisition Corp. | 55 Corporate Drive Bridgewater NJ 08807 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Acquisiton | 2010-02-09 | 28,864,905 | $93.50 | 44,622,694 | No | 4 | P | Indirect | By River Acquisition Corp. |
| Common Stock, Without Par Value | Acquisiton | 2010-02-09 | 552,321 | $93.50 | 45,175,015 | No | 4 | P | Indirect | By River Acquisition Corp. |
| Common Stock, Without Par Value | Acquisiton | 2010-02-10 | 300,936 | $93.50 | 45,475,951 | No | 4 | P | Indirect | By River Acquisition Corp. |
| Common Stock, Without Par Value | Acquisiton | 2010-02-11 | 923,268 | $93.50 | 46,399,219 | No | 4 | P | Indirect | By River Acquisition Corp. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By River Acquisition Corp. |
| No | 4 | P | Indirect | By River Acquisition Corp. |
| No | 4 | P | Indirect | By River Acquisition Corp. |
| No | 4 | P | Indirect | By River Acquisition Corp. |
Footnotes
- Reflects shares acquired by Aventis Inc. ("Aventis") from Chattem, Inc. ("Chattem"), pursuant to the exercise of the "top-up" option provided for in the Agreement and Plan of Merger, dated as of December 20, 2009, among sanofi-aventis ("Parent"), River Acquisition Corp. (the "Purchaser") and Chattem, and subsequently contributed to the Purchaser.
- The shares are held by the Purchaser. The Purchaser is an indirect, wholly-owned subsidiary of Parent and a direct, wholly-owned subsidiary of Aventis. Aventis is a wholly-owned subsidiary of Sanofi-aventis Am??rique du Nord S.N.C. ("ADN"). ADN is a wholly-owned subsidiary of Parent. The shares may also be deemed to be indirectly beneficially owned by Parent, ADN and Aventis.
- Reflects shares purchased in a tender offer.
Billionaire Hedge Funds
